Holen Sie sich die Stockscreener-App
102.62
0.57%
-0.59
Schlusskurs vom Vortag:
$103.21
Offen:
$103.21
24-Stunden-Volumen:
1.91M
Relative Volume:
0.73
Marktkapitalisierung:
$13.33B
Einnahmen:
$692.26M
Nettoeinkommen (Verlust:
$-512.41M
KGV:
-24.20
EPS:
-4.24
Netto-Cashflow:
$-274.36M
1W Leistung:
-3.15%
1M Leistung:
+4.80%
6M Leistung:
+104.87%
1J Leistung:
+188.83%
1-Tages-Spanne:
$102.30
$105.67
1-Wochen-Bereich:
$100.67
$109.59
52-Wochen-Spanne:
$29.91
$112.42
Guardant Health Inc Stock (GH) Company Profile
Firmenname
Guardant Health Inc
Sektor
Branche
Telefon
855-698-8887
Adresse
3100 HANOVER STREET, PALO ALTO
Vergleichen Sie GH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
102.62 | 13.40B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
573.81 | 211.55B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.42 | 157.68B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
701.83 | 55.82B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
143.47 | 39.81B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.92 | 37.14B | 15.90B | 1.28B | 2.21B | 7.2842 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-09-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Overweight |
| 2025-04-10 | Eingeleitet | Mizuho | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-28 | Hochstufung | Guggenheim | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-24 | Fortgesetzt | Craig Hallum | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-11-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-27 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-26 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-03-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-11-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | Eingeleitet | Craig Hallum | Buy |
| 2022-10-06 | Eingeleitet | Stephens | Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-28 | Fortgesetzt | BTIG Research | Buy |
| 2022-02-24 | Bestätigt | Canaccord Genuity | Buy |
| 2022-02-24 | Bestätigt | Citigroup | Buy |
| 2022-02-24 | Bestätigt | Cowen | Outperform |
| 2022-02-24 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-24 | Bestätigt | SVB Leerink | Outperform |
| 2022-02-24 | Bestätigt | Stifel | Buy |
| 2022-02-24 | Bestätigt | Wells Fargo | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-11 | Eingeleitet | Stifel | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-06-12 | Eingeleitet | BTIG Research | Buy |
| 2020-02-21 | Eingeleitet | Guggenheim | Buy |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-08-07 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-04-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | Bestätigt | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-29 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Guardant Health Inc Aktie (GH) Neueste Nachrichten
Guardant Health director Talasaz sells $10.5 million in shares - Investing.com
Insider Sell: Kumud Kalia Sells 2,000 Shares of Guardant Health Inc (GH) - GuruFocus
Global ESR1 Mutated Metastatic Breast Cancer Diagnostics - openPR.com
Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy - pharmiweb.com
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Purchases New Holdings in Guardant Health, Inc. $GH - MarketBeat
Hood River Capital Management LLC Has $12.79 Million Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
Italian hospital launches on-site liquid biopsy testing with Guardant Health - Investing.com Canada
Guardant Health, Inc. $GH Shares Bought by Invesco Ltd. - MarketBeat
JPMorgan Chase & Co. Decreases Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health Insider Sold Shares Worth $3,241,621, According to a Recent SEC Filing - marketscreener.com
Guardant Health Insider Sold Shares Worth $8,288,742, According to a Recent SEC Filing - marketscreener.com
Guardant Health Insider Sold Shares Worth $3,066,817, According to a Recent SEC Filing - marketscreener.com
Guardant Health (NASDAQ:GH) Insider Chris Freeman Sells 31,452 Shares - MarketBeat
Insider Sell Alert: Chris Freeman Sells 31,452 Shares of Guardan - GuruFocus
Guardant Health: chief commercial officer sells $3.24 million in stock By Investing.com - Investing.com Canada
Guardant Health: chief commercial officer sells $3.24 million in stock - Investing.com
Guardant Health CFO Bell sells $8.29 million in shares By Investing.com - Investing.com India
Guardant Health CFO Bell sells $8.29 million in shares - Investing.com
Freenome inks deals to list stock and raise $330M - MedTech Dive
Hsbc Holdings PLC Grows Position in Guardant Health, Inc. $GH - MarketBeat
Why Guardant Health (GH) Is Down 5.9% After Big Q3 Beat And Major Capital Raise – And What's Next - Yahoo Finance
Guardant Health (NASDAQ:GH) Trading Down 4.7%Time to Sell? - MarketBeat
Norges Bank Purchases New Position in Guardant Health, Inc. $GH - MarketBeat
Extending cancer prevention’s reach - Fast Company
Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium - Bakersfield.com
Edgestream Partners L.P. Buys 30,094 Shares of Guardant Health, Inc. $GH - MarketBeat
Insider Selling: Guardant Health (NASDAQ:GH) Insider Sells 55,167 Shares of Stock - MarketBeat
How Guardant Health Inc. (5GH) stock compares with top peers2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
How supply shortages influence Guardant Health Inc. (5GH) stock2025 Key Lessons & Safe Capital Allocation Plans - Newser
Is Guardant Health (GH) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Is Guardant Health Inc. (5GH) stock a fit for income portfoliosMarket Volume Summary & Free Technical Pattern Based Buy Signals - Newser
Will Guardant Health Inc. stock deliver long term returnsJuly 2025 Catalysts & Detailed Earnings Play Strategies - Newser
Guardant Health Insider Sold Shares Worth $5,846,163, According to a Recent SEC Filing - marketscreener.com
Guardant Health (GH) chief people officer sells $5.8m in stock By Investing.com - Investing.com Canada
Guardant Health (GH) chief people officer sells $5.8m in stock - Investing.com Canada
BioMark Diagnostics receives Innovation Award for lung cancer screening project - Mugglehead Magazine
Why Guardant Health (GH) Stock Is Up Today - Finviz
Guardant Health Stock Surges 46% In A Single Month, Wait For A Dip To Buy The Stock - Trefis
What RSI levels show for Guardant Health Inc. (5GH) stockJuly 2025 Recap & Community Verified Trade Signals - Newser
Legal & General Group Plc Has $8.23 Million Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. $GH Shares Sold by Granite Investment Partners LLC - MarketBeat
Morgan Stanley Raises Price Target for Guardant Health (GH) to $130 | GH Stock News - GuruFocus
Morgan Stanley Raises Price Target on Guardant Health to $130 From $105, Keeps Overweight Rating - marketscreener.com
Will Guardant Health Inc. (5GH) stock gain from green policiesEntry Point & Step-by-Step Swing Trade Plans - Newser
Is Guardant Health Inc. (5GH) stock nearing a technical breakoutWeekly Trade Recap & Weekly Return Optimization Alerts - Newser
Sen. Sheldon Whitehouse Purchases Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
GUARDANT HEALTH INC (1GH.MI) options chain - Yahoo Finance UK
GUARDANT HEALTH INC (1GH.MI) interactive stock chart - Yahoo Finance UK
GUARDANT HEALTH INC (1GH.MI) analyst ratings, estimates and forecasts - Yahoo Finance UK
GUARDANT HEALTH INC (1GH.MI) income statement - Yahoo Finance UK
How Guardant Health Inc. stock trades during market volatilityOil Prices & Risk Managed Investment Signals - Newser
Finanzdaten der Guardant Health Inc-Aktie (GH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.10%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):